Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Cathy Eng, James C. Yao et al.|The Lancet|2023Cited by 319
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerGeoff Chong, J Carmichael, Anish Bhatnagar et al.|Annals of Oncology|2005Cited by 32
Comparison of radiologically inserted arm ports <i>versus</i> surgically placed chest ports for chemotherapyAndrew Weickhardt, Geoff Chong, Timothy Joseph et al.|Asia-Pacific Journal of Clinical Oncology|2009Cited by 10